standard and alternative dosing regimens of immunotherapies and combinations in modern oncology
Published 3 years ago • 312 plays • Length 26:32Download video MP4
Download video MP3
Similar videos
-
1:25:42
navigating immunotherapies and combinations in the search for the best strategy for each patient
-
38:09
understanding and working with new immunotherapeutic and targeted management models in advanced rcc
-
28:23
biomarkers, immunotherapies, combinations, and other emerging approaches for lung cancer
-
1:29:06
leveraging neoadjuvant and adjuvant immunotherapy to improve outcomes in early-stage cancers
-
1:28:18
navigating evolving standards of care in rcc: novel targeted and immunotherapy options
-
1:50:50
emerging biomarkers, new targets, and rational combinations in immuno-oncology
-
49:39
advances in endometrial carcinoma treatment: the power of immunotherapy and other emerging regimens
-
39:16
where to next in limited-stage small cell lung cancer? the role of immune checkpoint inhibitors
-
1:01:58
essential conversations for hcc: radiology-oncology collaboration and immunotherapy advances
-
39:06
expanding the benefits of immuno-oncology through novel rational targets and combinations
-
33:06
maximizing the of potential current and emerging immunotherapies in advanced endometrial cancer
-
1:26:59
progress in immunotherapy biomarker testing and pathologic response assessment in solid tumors
-
57:18
translating progress with immunotherapies and targeted agents into improved outcomes in tnbc
-
1:05:54
melanoma care: continued progress with immunotherapy in resectable and unresectable disease
-
59:06
gastric and gej cancers: treatment planning and sequencing in the era of immunotherapy
-
1:09:47
evidence and insights on innovative treatment for bladder cancer
-
1:03:55
the nuances of immunotherapy biomarker testing in solid tumors
-
54:59
linking immunotherapy to better outcomes in resectable melanoma
-
56:08
gaining confidence in predicting and assessing response to cancer immunotherapies